卵巢癌中的多抑制器复合体1 (PRC1):一个范围的文献综述
Jessica Floyd1, Kristen DeSanto2, Benjamin G Bitler3
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado, Anschutz Medical Campus, 12700 E. 19th Avenue, Aurora, CO 80045, USA.
聚抑制剂复合体1 (PRC1) 蛋白质通过维持类似干细胞来促进耐化学反应的卵巢癌复发. 向PRC1可能为高度血清癌 (HGSC) 提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 高度血清瘤 (HGSC) 是最致命的卵巢癌亚型,经常与化疗抗性复发.
- 癌症干细胞表型有助于HGSC的化学抵抗和复发.
- 聚抑制复合体 (PRC1/2) 涉及到干细胞的维护和癌症的发展.
研究的目的:
- 审查PRC1的蛋白质成分及其在HGSC化学抵抗和复发中的作用.
- 探索针对卵巢癌中PRC1的潜在治疗研究.
主要方法:
- 使用Covidence进行了范围文献审查.
- 在MEDLINE,Embase,Cochrane图书馆和Web of Science核心集合中进行了文学搜索.
- 文章根据标题,摘要和全文审查进行了选.
主要成果:
- 确定了PRC1子单元对高高分子菌体发展,复发和化学抗性的贡献机制.
- 突出了PRC1在维持干状表型驱动治疗耐药性的作用.
- 汇总了关于PRC1在卵巢癌进展中的作用的现有知识.
结论:
- 在促进HGSC复发和化学抵抗方面,PRC1子单位至关重要.
- 对PRC1进行进一步的研究是有必要的,以开发HGSC的新治疗方法.
- 准PRC1为推进HGSC治疗提供了一个有希望的途径.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
相关概念视频
Abnormal Proliferation
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
